Briggs Simon, Ellis-Pegler Rod, Raymond Nigel, Thomas Mark, Wilkinson Lucille
Department of Infectious Diseases, Auckland Hospital, Auckland, New Zealand.
Scand J Infect Dis. 2004;36(3):165-73. doi: 10.1080/00365540410027193.
In order to assess the clinical features, aetiology, treatment and outcome of post-neurosurgical and post-traumatic Gram-negative bacillary meningitis (GNBM) we performed a retrospective review of all adult patients admitted to the Department of Neurosurgery who had Gram-negative bacilli cultured from cerebrospinal fluid (CSF) following a neurosurgical procedure or traumatic head/spinal injury. During the 12 y of the review 33 patients had CSF isolates of Gram-negative bacilli that were thought to be significant. The median patient age was 47 y (range 22-77 y) and 21 (64%) were male. Klebsiella pneumoniae, Enterobacter cloacae and Escherichia coli were the most common isolates. Minimal inhibitory concentrations (MIC) measured for half the patients' isolates resulted in 5 regimen changes, including 2 patients with E. cloacae meningitis in whom cephalosporin susceptibility decreased during cephalosporin treatment. Our recommended initial treatment was intravenous ceftriaxone and amikacin, subsequently tailored by susceptibility results; approximately half the patients remained on the antibiotics they started and half were changed to an alternate regimen, most often a carbapenem. Five patients (15%) died, 1 dying after cure of his GNBM. There were no failures in those who received more than 12 d of appropriate treatment: treatment for at least 14 d after the last positive CSF culture guaranteed cure. Initial ceftriaxone and amikacin subsequently changing to susceptibility driven alternatives, often a carbapenem, resulted in cure of 85% of our patients with GNBM.
为了评估神经外科手术后及创伤后革兰阴性杆菌性脑膜炎(GNBM)的临床特征、病因、治疗及预后,我们对神经外科收治的所有成年患者进行了回顾性研究,这些患者在神经外科手术或头部/脊柱创伤后,脑脊液(CSF)培养出革兰阴性杆菌。在回顾的12年中,33例患者的脑脊液分离出革兰阴性杆菌,被认为具有临床意义。患者的中位年龄为47岁(范围22 - 77岁),21例(64%)为男性。肺炎克雷伯菌、阴沟肠杆菌和大肠埃希菌是最常见的分离菌株。对一半患者的分离菌株进行的最低抑菌浓度(MIC)测定导致5次治疗方案更改,包括2例阴沟肠杆菌脑膜炎患者,在头孢菌素治疗期间头孢菌素敏感性降低。我们推荐的初始治疗是静脉注射头孢曲松和阿米卡星,随后根据药敏结果调整;约一半患者继续使用起始的抗生素,另一半则更换为替代方案,最常用的是碳青霉烯类。5例患者(15%)死亡,1例在GNBM治愈后死亡。接受超过12天适当治疗的患者无一治疗失败:在最后一次脑脊液培养阳性后至少治疗14天可确保治愈。初始使用头孢曲松和阿米卡星,随后更换为根据药敏结果选择的替代药物,通常是碳青霉烯类,使我们85%的GNBM患者得以治愈。